<bill session="116" type="h" number="5382" updated="2022-10-28T01:46:00Z">
  <state datetime="2019-12-10">REFERRED</state>
  <status>
    <introduced datetime="2019-12-10"/>
  </status>
  <introduced datetime="2019-12-10"/>
  <titles>
    <title type="display">To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.</title>
    <title type="official" as="introduced">To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.</title>
  </titles>
  <sponsor bioguide_id="F000449"/>
  <cosponsors/>
  <actions>
    <action datetime="2019-12-10">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-12-10" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-12-11">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Health care coverage and access"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2021-08-26T21:35:30Z" status="Introduced in House">This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.</summary>
</bill>
